Literature DB >> 28458087

Reenergizing T cell anti-tumor immunity by harnessing immunometabolic checkpoints and machineries.

Ping-Chih Ho1, Susan M Kaech2.   

Abstract

T cells patrol our bodies preventing pathogenic infections and malignant cell outgrowth. However, T cells must be properly controlled because aberrant or persistent T cell responses can damage tissues and contribute to autoimmune diseases and other chronic inflammatory diseases including metabolic syndrome. One regulatory mechanism utilized in immune cells is immunometabolic regulation, which ensures immune cells properly respond to systemic and peripheral metabolic cues. Recent work has suggested that deregulated metabolism in tumor cells creates a microenvironmental barrier for mounting effective anti-tumor immune responses. Here, we discuss how tumor cells evade immunosurveillance by modulating metabolic checkpoints in immune cells and discuss how memory T cells could provide effective anti-tumor responses by sustaining metabolic fitness and longevity.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28458087      PMCID: PMC5554719          DOI: 10.1016/j.coi.2017.04.003

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  70 in total

Review 1.  The three main stumbling blocks for anticancer T cells.

Authors:  Lukas Baitsch; Silvia A Fuertes-Marraco; Amandine Legat; Christiane Meyer; Daniel E Speiser
Journal:  Trends Immunol       Date:  2012-03-23       Impact factor: 16.687

2.  Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.

Authors:  Stefani Spranger; Riyue Bao; Thomas F Gajewski
Journal:  Nature       Date:  2015-05-11       Impact factor: 49.962

3.  L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells.

Authors:  F Taheri; J B Ochoa; Z Faghiri; K Culotta; H J Park; M S Lan; A H Zea; A C Ochoa
Journal:  Clin Cancer Res       Date:  2001-03       Impact factor: 12.531

4.  Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Rahul Roychoudhuri; David Clever; Alena Gros; Robert L Eil; Eric Tran; Ken-Ichi Hanada; Zhiya Yu; Douglas C Palmer; Sid P Kerkar; Ryan D Michalek; Trevor Upham; Anthony Leonardi; Nicolas Acquavella; Ena Wang; Francesco M Marincola; Luca Gattinoni; Pawel Muranski; Mark S Sundrud; Christopher A Klebanoff; Steven A Rosenberg; Douglas T Fearon; Nicholas P Restifo
Journal:  Cancer Res       Date:  2014-11-28       Impact factor: 12.701

5.  Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α.

Authors:  Sangbin Lim; Hao Liu; Luciana Madeira da Silva; Ritu Arora; Zixing Liu; Joshua B Phillips; David C Schmitt; Tung Vu; Steven McClellan; Yifeng Lin; Wensheng Lin; Gary A Piazza; Oystein Fodstad; Ming Tan
Journal:  Cancer Res       Date:  2016-04-05       Impact factor: 12.701

6.  ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis.

Authors:  Juan R Cubillos-Ruiz; Pedro C Silberman; Melanie R Rutkowski; Sahil Chopra; Alfredo Perales-Puchalt; Minkyung Song; Sheng Zhang; Sarah E Bettigole; Divya Gupta; Kevin Holcomb; Lora H Ellenson; Thomas Caputo; Ann-Hwee Lee; Jose R Conejo-Garcia; Laurie H Glimcher
Journal:  Cell       Date:  2015-06-11       Impact factor: 41.582

7.  Functional polarization of tumour-associated macrophages by tumour-derived lactic acid.

Authors:  Oscar R Colegio; Ngoc-Quynh Chu; Alison L Szabo; Thach Chu; Anne Marie Rhebergen; Vikram Jairam; Nika Cyrus; Carolyn E Brokowski; Stephanie C Eisenbarth; Gillian M Phillips; Gary W Cline; Andrew J Phillips; Ruslan Medzhitov
Journal:  Nature       Date:  2014-07-13       Impact factor: 69.504

8.  Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models.

Authors:  Robert U Svensson; Seth J Parker; Lillian J Eichner; Matthew J Kolar; Martina Wallace; Sonja N Brun; Portia S Lombardo; Jeanine L Van Nostrand; Amanda Hutchins; Lilliana Vera; Laurie Gerken; Jeremy Greenwood; Sathesh Bhat; Geraldine Harriman; William F Westlin; H James Harwood; Alan Saghatelian; Rosana Kapeller; Christian M Metallo; Reuben J Shaw
Journal:  Nat Med       Date:  2016-09-19       Impact factor: 53.440

9.  PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.

Authors:  David K Finlay; Ella Rosenzweig; Linda V Sinclair; Carmen Feijoo-Carnero; Jens L Hukelmann; Julia Rolf; Andrey A Panteleyev; Klaus Okkenhaug; Doreen A Cantrell
Journal:  J Exp Med       Date:  2012-11-26       Impact factor: 14.307

10.  Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy.

Authors:  Mahima Swamy; Shalini Pathak; Katarzyna M Grzes; Sebastian Damerow; Linda V Sinclair; Daan M F van Aalten; Doreen A Cantrell
Journal:  Nat Immunol       Date:  2016-04-25       Impact factor: 25.606

View more
  14 in total

1.  Clonal expansion of vaccine-elicited T cells is independent of aerobic glycolysis.

Authors:  Jared Klarquist; Alisha Chitrakar; Nathan D Pennock; Augustus M Kilgore; Trevor Blain; Connie Zheng; Thomas Danhorn; Kendra Walton; Li Jiang; Jie Sun; Christopher A Hunter; Angelo D'Alessandro; Ross M Kedl
Journal:  Sci Immunol       Date:  2018-09-07

Review 2.  Breast Cancer Immunotherapy: Facts and Hopes.

Authors:  Leisha A Emens
Journal:  Clin Cancer Res       Date:  2017-08-11       Impact factor: 12.531

3.  Molecular MRI of the Immuno-Metabolic Interplay in a Rabbit Liver Tumor Model: A Biomarker for Resistance Mechanisms in Tumor-targeted Therapy?

Authors:  Lynn Jeanette Savic; Luzie A Doemel; Isabel Theresa Schobert; Ruth Rebecca Montgomery; Nikhil Joshi; John James Walsh; Jessica Santana; Vasily Pekurovsky; Xuchen Zhang; MingDe Lin; Lucas Adam; Annemarie Boustani; James Duncan; Lin Leng; Richard John Bucala; S Nahum Goldberg; Fahmeed Hyder; Daniel Coman; Julius Chapiro
Journal:  Radiology       Date:  2020-07-07       Impact factor: 11.105

4.  Lack of Sprouty 1 and 2 enhances survival of effector CD8+ T cells and yields more protective memory cells.

Authors:  Hesham M Shehata; Shahzada Khan; Elise Chen; Patrick E Fields; Richard A Flavell; Shomyseh Sanjabi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-20       Impact factor: 11.205

5.  No Oxygen? No Glucose? No Problem: Fatty Acid Catabolism Enhances Effector CD8+ TILs.

Authors:  Will Bailis; Justin A Shyer; Michael Chiorazzi; Richard A Flavell
Journal:  Cancer Cell       Date:  2017-09-11       Impact factor: 31.743

6.  D-2-Hydroxyglutarate Is an Intercellular Mediator in IDH-Mutant Gliomas Inhibiting Complement and T Cells.

Authors:  Lingjun Zhang; Mia D Sorensen; Bjarne W Kristensen; Guido Reifenberger; Thomas M McIntyre; Feng Lin
Journal:  Clin Cancer Res       Date:  2018-07-13       Impact factor: 12.531

7.  Metabolic modeling of single Th17 cells reveals regulators of autoimmunity.

Authors:  Allon Wagner; Chao Wang; Johannes Fessler; David DeTomaso; Julian Avila-Pacheco; James Kaminski; Sarah Zaghouani; Elena Christian; Pratiksha Thakore; Brandon Schellhaass; Elliot Akama-Garren; Kerry Pierce; Vasundhara Singh; Noga Ron-Harel; Vivian Paraskevi Douglas; Lloyd Bod; Alexandra Schnell; Daniel Puleston; Raymond A Sobel; Marcia Haigis; Erika L Pearce; Manoocher Soleimani; Clary Clish; Aviv Regev; Vijay K Kuchroo; Nir Yosef
Journal:  Cell       Date:  2021-07-02       Impact factor: 66.850

Review 8.  Creatine in T Cell Antitumor Immunity and Cancer Immunotherapy.

Authors:  Bo Li; Lili Yang
Journal:  Nutrients       Date:  2021-05-13       Impact factor: 5.717

Review 9.  Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer.

Authors:  Ivan J Cohen; Ronald Blasberg
Journal:  Breast Cancer (Auckl)       Date:  2017-09-25

10.  Creatine uptake regulates CD8 T cell antitumor immunity.

Authors:  Stefano Di Biase; Xiaoya Ma; Xi Wang; Jiaji Yu; Yu-Chen Wang; Drake J Smith; Yang Zhou; Zhe Li; Yu Jeong Kim; Nicole Clarke; Angela To; Lili Yang
Journal:  J Exp Med       Date:  2019-10-18       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.